Lyell Immunopharma, Inc.
- LYEL
- NASDAQ
- Biotechnology
- Cell Therapy (CAR-T)
- Immuno-Oncology
- Biotech (Cell Therapy)
$8.12
Today −0.85%Quote Oct 16, 2026, 08:00 PM UTC
−24.81%over the last month
Max drawdown −32.6%From 1-month high −27.2%3 months −37.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$199.0M
Quote Oct 16
Next earnings
Nov 10
Expected, not confirmed
Analyst target
$42.67
+425.5% from here
Floor
$7.81
3.8% below price
Where the price sits
7 analysts
Analyst range, low to high
$34.00$49.00
- Price $8.12
- Resistance $8.18
- Consensus $42.67
The price is right under resistance. Analysts' average target sits about 425% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LYELPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
161
Founded
2018